Fecal Microbiota Transplantation is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection.

Christian Lodberg Hvas,Simon Mark Dahl Jørgensen,Søren Peter Jørgensen,Merete Storgaard,Lars Lemming,Mette Mejlby Hansen,Christian Erikstrup,Jens Frederik Dahlerup

Gastroenterology（2019）

引用 246|浏览16

暂无评分

摘要

In a randomized trial of patients with rCDI, we found the combination of vancomycin and FMT to be superior to fidaxomicin or vancomycin, based on endpoints of clinical and microbiological resolution or clinical resolution alone. ClinicalTrials.gov no: NCT02743234. EudraCT j.no: 2015-003004-24.

查看译文

关键词

Microbiome,Bacteria,Comparison,Antibiotic

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要